Licoser Plus 30 Tabs

LICOSER Plus

Dietary supplement based on saw palmetto, lycopene, green tea, stinging nettle; supporting the maintenance of the physiological properties of the prostate gland.
Does not contain gluten or sugars.
       Serenoa Repens (synonym of Sabal Serrulata)
Plant widespread in the United States, Southern Europe, and North Africa. The most important chemical constituents are various sterols, free fatty acids, carotenoids, essential oils, and polysaccharides.
Useful for proper functioning of the urinary tract and the prostate.
       Lycopene
Natural pigment belonging to the carotenoid class, characterized by antioxidant properties similar to those of beta-carotene, but much more powerful, thus more effective in preventing damage caused by oxygen free radicals. In nature, lycopene is present in tomatoes and other plant substances; with high antioxidant activity, it is considered among carotenoids the most powerful ""scavenger"" of oxygen free radicals.
       Urtica Dioica
Perennial herbaceous plant native to Western Asia, widespread in all temperate regions, including Italy. In modern herbal medicine, the root plays a leading role, in fact, it is rich in phytosterols (α-sitosterol, daucosterol, and related glucosides), with a mechanism of action similar to that of Serenoa but also contains lectins (scopoletin) that inhibit EGF (Epidermal Growth Factor), a growth factor capable of reducing symptoms and partially also the volume of the gland. Therefore, the extract of Urtica Dioica root is particularly beneficial in limiting the growth of prostatic tissue induced by androgens, especially dihydrotestosterone.
       Green Tea
Derived from the buds of the leaves and young leaves of the plant known scientifically as ""Camellia sinensis"". The peculiarity of this plant is given by its high antioxidant potential.

Ingredients
300 mg

	per 1 tablet (1300 mg)
Serenoa Repens (dry extract 45% fatty acids)	450 mg
Urtica dioica dry extract (Radix)
Green tea (Catechins)	100 mg
Lycopene	10 mg

Usage modes
It is recommended to take 1 tablet per day before meals for a period of no less than 3/4 months.

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Supplements are not to be understood as substitutes for a varied diet. For pregnant or breastfeeding women and children, it is recommended to consult a doctor.

Format
Package of 30 tablets of 1300 mg.

Code 1010020.

Bibliography
  -   Carilla E, Briley M, Fauran F, Sultan C, Duvilliers C. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. J Steroid Biochem 1984;20:521-3.
  -   Champault G, Patel JC, Bonnard QAM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br J Clin Pharmacol 1984;18:461-2.
  -   De Bruyne F. et al. Evaluation of the clinical benefit SerenoaRepens and Tamsulosin in severe BPH patients-Personal study subset analysis.Eur.Urol. 2004 Jun;45(6):773-9;Discussion 779-80,2004.
  -   Boyle P, Robertson C, Lowe F, Roehrborn C. Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 2000;55:533-9.
  -   Bent S. et al. Saw Palmetto for benign prostatic hyperplasia. N.Engl.J. Med. 354(6):557-66,2006.
  -   Wilt T, Ishani A, Stark G, Macdonald R, Mulrow C, Lau J. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2000;2:CD001423.
  -   Fong YK, Milani S, Djavan B, Role of phytotherapy in men with lower urinary tract symptoms. Curr opinion urol.2005; 15(1); 45-48.
 -   Wilt T, Ishani A, Mac Donald R, Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev,2002; 3 ; CDCD001423.
  -   Strauch G, Perles P, Vergult G, et al. Comparison of finasteride and Serenoa repens in the inhibition of 5-alpha reductase in healthy male volunteers. Eur.Urology 1994; 26:3, 247-252.
  -   Debruyne F, Boyle P, Calais da Silva F, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela- Navarrete R, Raynaud JP, Schulman C, Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients - PERMAL study subset analysis. Prog Urol, 2004 Jun;14(3):326-331.
  -   Avins A.L. et al. A detailed safety assessment of a Saw Palmetto extract. Complement ther med. 16(3):147-154,2008.
  -   Levy J., Bosin E. et al., Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr. Cancer,1995;24: 257-266.
  -   Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU int 200; 86(4):439-442.
  -   Schneider T, Rubben H, Stinging nettle root extract in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months. Urologe A, 2004; 43(3): 302-306.
  -   Lichius JJ, The inhibiting effects of components of stinging nettle roots on experimentally induced prostatic hyperplasia in mice. PlantaMed,1999;65,7: 666-668.
  -   Bombardelli E, Morazzoni P, Urtica Dioica L. Fitoterapia 1997;68,5, 387-402.
  -   Chem Pharm, Bulletin 38-1990.
  -   Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS, Japan Public Health Center- Based Prospective Study Group. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev, 2008 Apr; 17 (4): 930-937.
  -   Betuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A, Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. cancer Res,2006 Jan 15;66(2): 1234-1240.
  -   Etminan M, Takkouche B, Caamano-Isorna F The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev, 2004 Mar; 13 (3): 340-345.
  -   Michael B. Sporn and Karen T. Liby Is Lycopene an effective Agent for preventing prostate cancer Cancer Prevention Research 14-03-2013.